EGFR and tuberous sclerosis: In this context, an improved understanding of the molecular mechanisms underlying epileptogenesis, brain tumours, and kidney cysts formation has shed light on ion channels and other synaptic proteins, AMPK, inflammatory markers, and EGFR as potential drug targets to restore hyperexcitability and cell growth, thus providing new avenues of drug discovery for TSC.